The operation will begin this Monday in neighborhoods of the cities of Santa Fe, Rosario and Rafaela and towns in the north of the province.
Just like the province of Buenos Aires, Santa Fe announced that The free vaccination operation against dengue will beginin view of the arrival of mosquitoes with the rise in temperatures in the summer.
Those who will receive the dengue vaccine starting this Monday will be young people from 15 to 19 years old from neighborhoods in the city of Santa Fe, Rosario and Rafaela and towns in the north of the province. In a second stage, health personnel, firefighters, police officers and other strategic personnel will be vaccinated. 20 to 39 years.
The government of Maximiliano Pullaro invested 8 billion pesos in the operation, according to information from the Ministry of Health of Santa Fe. At the moment, the province has already acquired 160,000 doses, a percentage has already arrived in the territory and Distribution in Santa Fe hospitals has already begun.
dengue vaccine
The head of Health, Silvia Sancio, specified that the people who will be inoculated “They are identified by name and surname” and will be called to begin the campaign next week.
“In the first stage, we will vaccinate adolescents and young people aged 15 to 19. This is a recommendation from the National Immunization Commission, which calls for starting it at this stage,” said the official. In a second moment, In mid-September, health personnel, firefighters, police officers and other strategic personnel aged 20 to 39 will be vaccinated,” the official added.
The province of Buenos Aires launched the vaccination campaign against dengue
The province of Buenos Aires launched a similar operation with the aim of avoiding a new outbreak during the next 2024-2025 season. It announced the acquisition of 500,000 doses of the Qdenga dengue vaccinerecommended by the World Health Organization (WHO) for its safety and effectiveness.
The Minister of Health of Buenos Aires, Nicholas Kreplak, reported that vaccination will begin in October. The vaccine, produced by the laboratory Takedademonstrated a 80% efficacy in reducing infections and 90% in severe cases. It is indicated for people of 15 to 59 years, with two doses administered: one initial and another three months later. The only contraindications are for pregnant, lactating or immunosuppressed people.
Source: Ambito
I am Pierce Boyd, a driven and ambitious professional working in the news industry. I have been writing for 24 Hours Worlds for over five years, specializing in sports section coverage. During my tenure at the publication, I have built an impressive portfolio of articles that has earned me a reputation as an experienced journalist and content creator.
